Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array.
Szarka A, Rigó J, Lázár L, Beko G, Molvarec A. · 2010
Read Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. by Szarka A, Rigó J, Lázár L, Beko G, Molvarec A. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3014878.txt.
Introduction
Szarka and colleagues ran a 2010 study of immune signal molecules in blood. They compared healthy pregnancies with preeclampsia. That dangerous complication of pregnancy is marked by body-wide inflammation. Single markers had given a patchy picture.
Sixty patients, sixty healthy pregnant women, and about sixty non-pregnant controls were compared using a multiplex array plus targeted tests. Normal pregnancy already shifted the circulating mix, and preeclampsia shifted it further in characteristic directions. The team related the patterns to clinical features and to markers of vessel activation, oxidative stress, and debris from the placenta.
Catalog record
| CREATOR | Szarka A, Rigó J, Lázár L, Beko G, Molvarec A. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array By András Szarka, János Rigó, Levente Lázár, Gabriella Bekő, Attila Molvarec Published in: BMC Immunology DOI: 10.1186/1471-2172-11-59 ABSTRACT Abstract Background Preeclampsia is a severe complication of pregnancy characterized by an excessive maternal systemic inflammatory response with activation of both the innate and adaptive arms of the immune system. Cytokines, chemokines and adhesion molecules are central to innate and adaptive immune processes. The purpose of this study was to determine circulating levels of cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia in a comprehensive manner, and to investigate their relationship to the clinical features and laboratory parameters of the study participants, including markers of overall inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) and endothelial injury (fibronectin), oxidative stress (malondialdehyde) and trophoblast debris (cell-free fetal DNA). Results Serum levels of interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-12p70, IL-18, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, interferon-gamma-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-1, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were measured in 60 preeclamptic patients, 60 healthy pregnant women and 59 healthy non-pregnant women by multiplex suspension array and ELISA. In normal pregnancy, the relative abundance of circulating IL-18 over IL-12p70 and the relative deficiency of the bioactive IL-12p70 in relation to IL-12p40 might favour Th2-type immunity. Although decreased IL-1ra, TNF-alpha and MCP-1 concentrations of healthy pregnant relative to non-pregnant women reflect anti-inflammatory changes in circulating cytokine profile, their decreased serum IL-10 and increased IP-10 levels might drive pro-inflammatory responses. In addition to a shift towards Th1-type immunity (expressed by the increased IL-2/IL-4 and IFN-gamma/IL-4 ratios), circulating levels of the pro-inflammatory cytokines IL-6 and TNF-alpha, the chemokines IL-8, IP-10 and MCP-1, as well as the adhesion molecules ICAM-1 and VCAM-1, were raised in preeclampsia compared with healthy pregnancy, resulting in an overall pro-inflammatory systemic environment. Increased IP-10, MCP-1, ICAM-1 and VCAM-1 concentrations of preeclamptic patients showed significant correlations with blood pressure values, renal and liver function parameters, as well as with CRP, malondialdehyde, von Willebrand factor antigen and fibronectin levels. Conclusions According to our findings, preeclampsia was associated with an overall pro-inflammatory systemic environment. Elevated amounts of pro-inflammatory cytokines, chemokines and adhesion molecules in the maternal circulation might play a central role in the excessive systemic inflammatory response, as well as in the generalized endothelial dysfunction characteristics of the maternal syndrome of preeclampsia. BACKGROUND Preeclampsia, characterized by hypertension and proteinuria developing after midgestation, is a severe complication of human pregnancy with a worldwide incidence of 2-10%. It is one of the leading causes of maternal, as well as perinatal morbidity and mortality, even in developed countries. Despite intensive research efforts, the etiology and pathogenesis of preeclampsia are not completely understood. Increasing evidence suggests that an excessive maternal systemic inflammatory response to pregnancy with activation of both the innate and adaptive arms of the immune system is involved in the pathogenesis of the disease [1,2]. The development of preeclampsia is influenced by both genetic and environmental risk factors, suggesting its multifactorial inheritance [3-8]. An important feature of systemic inflammation in preeclampsia is the absence of Th2 skewness characteristic for healthy pregnancy, and thus the predominance of Th1-type immunity. Saito et al. reported firstly that the percentage of Th1 cells and the ratios of Th1/Th2 were significantly higher, while the percentage of Th2 cells was significantly lower in the peripheral blood in preeclampsia than in the third trimester of normal pregnancy [9]. In another study, this group observed increased production of interleukin (IL)-2, interferon (IFN)-γ and tumor necrosis factor (TNF)-α by peripheral blood mononuclear cells (PBMCs) in preeclampsia and, interestingly, positive correlations between mean blood pressure and concentrations of Th1 cytokines [10]. The shift to a predominant Th1-type immunity in preeclampsia was reinforced by other experiments on intracellular cytokine measurements in peripheral blood T (both helper and cytotoxic) cells and NK cells, as well as by assessment of cytokine secretion levels of PBMCs isolated from preeclamptic patients [11-14]. However, the studies on circulating levels of cytokines in normal pregnancy and preeclampsia yielded conflicting results [15,16]. The discrepancies may be due to different techniques used for cytokine detection, differences in the ethnicity of the study populations, disease severity or sample sizes. The aim of this study was to determine circulating levels of cytokines, chemokines and adhesion molecules in a comprehensive manner involving a large number of healthy non-pregnant and pregnant women and preeclamptic patients. We also measured several markers of processes involved in the pathogenesis of preeclampsia, and investigated whether serum cytokine, chemokine and adhesion molecule levels were related to the clinical characteristics and laboratory parameters of the study participants, including markers of overall inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) and endothelial injury (fibronectin), oxidative stress (malondialdehyde) and trophoblast debris (cell-free fetal DNA). METHODS Study patients Our study was designed using a case-controlled approach. Sixty preeclamptic patients, 60 healthy pregnant women with uncomplicated pregnancies and 59 healthy non-pregnant women were involved in the study. The study participants were enrolled in the First Department of Obstetrics and Gynecology and in the Department of Obstetrics and Gynecology of Kútvölgyi Clinical Center, at the Semmelweis University, Budapest, Hungary. All women were Caucasian and resided in the same geographic area in Hungary. Exclusion criteria were multifetal gestation, chronic hypertension, diabetes mellitus, autoimmune disease, angiopathy, renal disorder, maternal or fetal infection and fetal congenital anomaly. The women were fasting, none of the pregnant women were in active labor, and none had rupture of membranes. The healthy non-pregnant women were in the early follicular phase of the menstrual cycle (between cycle days 3 and 5), and none of them received hormonal contraception. Preeclampsia was defined by increased blood pressure (≥140 mmHg systolic or ≥90 mmHg diastolic on ≥2 occasions at least 6 hours apart) that occurred after 20 weeks of gestation in a woman with previously normal blood pressure, accompanied by proteinuria (≥0.3 g/24 h or ≥1 + on dipstick in the absence of urinary tract infection). Blood pressure returned to normal by 12 weeks postpartum in each preeclamptic study patient. Preeclampsia was regarded as severe if any of the following criteria was present: blood pressure ≥160 mmHg systolic or ≥110 mmHg diastolic, or proteinuria ≥5 g/24 h (or ≥3 + on dipstick). Pregnant women with eclampsia or HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) were not enrolled in this study. Early onset of preeclampsia was defined as onset of the disease before 34 weeks of gestation (between 20 and 33 completed gestational weeks). Fetal growth restriction was diagnosed if the fetal birth weight was below the 10th percentile for gestational age and gender, based on Hungarian birth weight percentiles [17]. The study protocol was approved by the Regional and Institutional Committee of Science and Research Ethics of the Semmelweis University, and written informed consent was obtained from each patient. The study was conducted in accordance with the Declaration of Helsinki. Biological samples Blood samples were taken from an antecubital vein into plain, as well as EDTA- or sodium citrate anticoagulated tubes, and then centrifuged at room temperature with a relative centrifugal force